Position in ELAN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$426,982
-$2,693 QoQ
Shares Held
17,843
-6.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $113,933,883 across 18 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
766,101 | $90,560,795 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
497,461 | $14,983,524 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
162,101 | $3,365,216 | |
| 4 | ALKS |
Alkermes plc.
|
32,101 | $1,135,090 | |
| 5 | LQDA |
Liquidia Corp
|
17,610 | $664,601 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
813 | $482,091 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
17,843 | $426,982 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
2,828 | $372,559 |
All Filings in ELAN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $426,982 | 17,843 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $429,675 | 18,987 | Shares | Defined | 2026-02-13 | |
| 2021-12-31 | $342,800 | 12,079 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $242,491 | 7,604 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $263,782 | 7,604 | Shares | Defined | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||